The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures,
Discuss the current landscape of Monkeypox in the U.S and infection prevention considerations for evaluation and management in healthcare settings. Describe the clinical presentation in ambulatory and inpatient settings, as
The 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) public meeting is tentatively being planned as an in-person event on September 12 and September 13, 2022. The meeting
Fungal Disease Awareness Week is September 19–23, 2022. CDC and partners have organized this week to highlight the importance of antifungal stewardship, reducing resistance to antifungal drugs, and recognizing serious
The 21st Congress of the International Society for Human and Animal Mycology will be Highlighted topics of interest include: Veterinary relevant and zoonotic fungal groups Development of WHO priority pathogens
The Scientific Advisory Committee on Alternative Toxicological Methods will meet 21-22 September 2022. This is a Save-the-Date posting. Further details will be made available at the National Toxicology Program website
The U.S. Food and Drug Administration (FDA) will host a virtual town hall for monkeypox test developers on 21 September 2022. The purpose of these town halls is to help
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene on 22 September 2022 to discuss the Biologics License Application # 125739 (BLA - 125739) from Rebiotix Inc. for
Hear insights and information from APHIS and other experts on steps to take and what to expect during a bird flu outbreak during a free webinar on 22 September 2022.
